Gilead Sciences Investment Purchases increased by 100.7% to $14.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 64.1%, from $39.00M to $14.00M. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows a downward trend with a -23.1% CAGR.
An increase indicates a surplus of cash being deployed into financial markets rather than core operations; a decrease may suggest a need for liquidity.
The total cash outflow for the acquisition of debt and equity securities, including marketable securities and other fina...
Large-cap technology firms often show high outflows here as they manage massive cash reserves across global portfolios.
cf_purchases_of_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.00M | $31.00M | $48.00M | $28.00M | $16.00M | $122.00M | $6.00M | $125.00M | $67.00M | $26.00M | $224.00M | $410.00M | $34.00M | $9.00M | $39.00M | $16.00M | $2.00B | -$1.90B | $14.00M |
| QoQ Change | — | +40.9% | +54.8% | -41.7% | -42.9% | +662.5% | -95.1% | >999% | -46.4% | -61.2% | +761.5% | +83.0% | -91.7% | -73.5% | +333.3% | -59.0% | >999% | -194.8% | +100.7% |
| YoY Change | — | — | — | — | -27.3% | +293.5% | -87.5% | +346.4% | +318.8% | -78.7% | >999% | +228.0% | -49.3% | -65.4% | -82.6% | -96.1% | >999% | <-999% | -64.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.